help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lewinsohn, D. A.
Right arrow Articles by Lewinsohn, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lewinsohn, D. A.
Right arrow Articles by Lewinsohn, D. M.
American Journal of Respiratory and Critical Care Medicine Vol 166. pp. 843-848, (2002)
© 2002 American Thoracic Society


Original Article

Human Dendritic Cells Presenting Adenovirally Expressed Antigen Elicit Mycobacterium tuberculosis–Specific CD8+ T Cells

Deborah A. Lewinsohn, Rebecca A. Lines and David M. Lewinsohn

Division of Pediatric Infectious Diseases, Department of Molecular Microbiology and Immunology; and Division of Pulmonary and Critical Care Medicine, Oregon Health and Science University/Portland VA Medical Center, Portland, Oregon

Correspondence and requests for reprints should be addressed to Dr. David Lewinsohn, R&D 11, Portland VA Medical Center, 3710 SW US Veterans Road, Portland, OR 97201. E-mail: lewinsod{at}ohsu.edu

Previous studies in murine and human models have suggested an important role for CD8+ T cells in host defense to Mycobacterium tuberculosis (Mtb). Consequently, a successful tuberculosis vaccine may require the elicitation of sustained CD4+ and CD8+ T cell responses. We tested the hypothesis that the potent CD4+ T cell antigen Mtb39 is also a CD8+ T cell antigen. A recombinant adenovirus–expressing Mtb39 (adenoMtb39) was used to infect monocyte-derived dendritic cells. Using interferon-{gamma} enzyme-linked immunospot, Mtb39-specific CD8+ T lymphocytes were detected in three healthy individuals with latent tuberculosis infection who also had strong anti–Mtb39-specific CD4+ T cell responses. An Mtb39-specific CD8+ T cell line was generated using Mtb39-expressing dendritic cells. Mtb39-specific T cell clones were obtained by limiting dilution cloning. All seven T cell clones obtained were HLA-B44 restricted. Using a panel of synthetic overlapping peptides representative of Mtb39, the peptide epitope was identified for two clones. Furthermore, all T cell clones recognized Mtb-infected dendritic cells and were cytolytic. We conclude that infection of dendritic cells with adenoviral vectors expressing Mtb proteins allows for measurement of antigen-specific CD8+ T cell responses from peripheral blood mononuclear cells. The technique will be useful in defining CD8+ T cell antigens and in measuring immunogenicity of tuberculosis vaccines.

Key Words: CD8-positive T lymphocytes • dendritic cells • tuberculosis




This article has been cited by other articles:


Home page
J. Immunol.Home page
D. M. Lewinsohn, J. E. Grotzke, A. S. Heinzel, L. Zhu, P. J. Ovendale, M. Johnson, and M. R. Alderson
Secreted Proteins from Mycobacterium tuberculosis Gain Access to the Cytosolic MHC Class-I Antigen-Processing Pathway
J. Immunol., July 1, 2006; 177(1): 437 - 442.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. Carranza, E. Juarez, M. Torres, J. J. Ellner, E. Sada, and S. K. Schwander
Mycobacterium tuberculosis Growth Control by Lung Macrophages and CD8 Cells from Patient Contacts
Am. J. Respir. Crit. Care Med., January 15, 2006; 173(2): 238 - 245.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
N. R. Hegde, C. Dunn, D. M. Lewinsohn, M. A. Jarvis, J. A. Nelson, and D. C. Johnson
Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL
J. Exp. Med., October 17, 2005; 202(8): 1109 - 1119.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. C. Derrick, C. Repique, P. Snoy, A. L. Yang, and S. Morris
Immunization with a DNA Vaccine Cocktail Protects Mice Lacking CD4 Cells against an Aerogenic Infection with Mycobacterium tuberculosis
Infect. Immun., March 1, 2004; 72(3): 1685 - 1692.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. Shams, P. F. Barnes, S. E. Weis, P. Klucar, and B. Wizel
Human CD8+ T cells recognize epitopes of the 28-kDa hemolysin and the 38-kDa antigen of Mycobacterium tuberculosis
J. Leukoc. Biol., December 1, 2003; 74(6): 1008 - 1014.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. A. Lewinsohn, A. S. Heinzel, J. M. Gardner, L. Zhu, M. R. Alderson, and D. M. Lewinsohn
Mycobacterium tuberculosis-specific CD8+ T Cells Preferentially Recognize Heavily Infected Cells
Am. J. Respir. Crit. Care Med., December 1, 2003; 168(11): 1346 - 1352.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. L. Johnson, E. Ssekasanvu, A. Okwera, H. Mayanja, C. S. Hirsch, J. G. Nakibali, D. D. Jankus, K. D. Eisenach, W. H. Boom, J. J. Ellner, et al.
Randomized Trial of Adjunctive Interleukin-2 in Adults with Pulmonary Tuberculosis
Am. J. Respir. Crit. Care Med., July 15, 2003; 168(2): 185 - 191.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
P. Kumar, R. R. Amara, V. K. Challu, V. K. Chadda, and V. Satchidanandam
The Apa Protein of Mycobacterium tuberculosis Stimulates Gamma Interferon-Secreting CD4+ and CD8+ T Cells from Purified Protein Derivative-Positive Individuals and Affords Protection in a Guinea Pig Model
Infect. Immun., April 1, 2003; 71(4): 1929 - 1937.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Tuberculosis, Lung Infections, Interstitial Lung Disease, and Journalology in AJRCCM 2002
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 345 - 355.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Lalvani
CD8 Cytotoxic T Cells and the Development of New Tuberculosis Vaccines
Am. J. Respir. Crit. Care Med., September 15, 2002; 166(6): 789 - 790.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2002 American Thoracic Society